3,5-cyclo-Abiraterone is derived from Abiraterone (A108490), which is a steroidal cytochrome P 450 17alpha-hydroxylase-17,20-lyase inhibitor (CYP17), is currently undergoing phase II clinical trials as a potential drug for the treatment of androgen-dependent prostate cancer. Molecular Formula: C24H31NO Solubility: Chloroform (Slightly), DMSO (Slightly) Molecular Weight: 349.51 Storage and Stability: Store at -20C. For maximum recovery of product, centrifuge the original vial prior to removing the cap.
Molecular Weight:
349.51
Form:
Supplied as a White Solid
* VAT and and shipping costs not included. Errors and price changes excepted
